Article

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?

2023-07-13

Abstract excerpt

Healthy carriers of BRCA1/2 pathogenic variants (PVs) may benefit from risk-reducing measures of proven efficacy. The main approach to identify these individuals is cascade testing, and strategies to support this complex process are under investigation. In Italy, cascade testing has received little attention; therefore, we analyzed the uptake and characteristics of BRCA1/2 cascade testing in families diagnosed wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: b41e4ae5-9051-5c7b-acd4-58313d7f83d7
DOI: 10.21203/rs.3.rs-3153904/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?DOI 10.21203/rs.3.rs-3153904/v1Read

Cascade testing in Italian Hereditary Breast Ovarian Cancer families: a missed opportunity for cancer prevention?Semantic proximity Read

Cascade testing as the missing link in cancer prevention among Lynch syndrome families.Semantic proximity Read

Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.Semantic proximity Read

Uptake of Cascade Genetic Testing for Hereditary Breast Cancer in the Public Health System in a Middle-Income Country: A Real-World Study.Semantic proximity Read

Cancer genetic counselling for hereditary breast cancer in the era of precision oncology.Semantic proximity Read

BRCA1 and BRCA2 genetic testing in Italian breast and/or ovarian cancer families: mutation spectrum and prevalence and analysis of mutation prediction modelsSemantic proximity Read

A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.Semantic proximity Read

Only 32.3% of Breast Cancer Families with Pathogenic Variants in Cancer Genes Utilized Cascade Genetic TestingSemantic proximity Read

Health Impact Assessment of BRCA1/2 Cascade Screening for the Personalized Prevention of Hereditary Breast and Ovarian Cancers in ItalySemantic proximity Read

Cascade genetic testing: an underutilized pathway to equitable cancer care?Semantic proximity Read

Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE CohortSemantic proximity Read

Index case identification and outcomes of cascade testing in high-risk breast and colorectal cancer predisposition genes.Semantic proximity Read